BGB-3290

N/A

Report date: 2022/01/05 15:24:33
NME

Base Information

Drug NameBGB-3290
Drug Alias NameBGB-3290
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionRAF serine/threonine protein kinase inhibitors
TargetsRAF serine/threonine protein kinase
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesBeigene Llc
China Registration ClassN/A

Develop Information

Active CompaniesBeigene Llc
Inactive CompaniesN/A
Active IndicationsN/A
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A